Becton Dickinson and Company (BDX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $59.39B
Last updated: Nov 17, 2026 at 11:05 AM ET
Becton Dickinson and Company (BDX) Financials: Revenue, Profit and Cash Flow
Becton Dickinson and Company reported revenue of $21.84B for the fiscal year ended Sep 30, 2025, up 8.2% from the year before. That year, net income was $1.68B with a net margin of 7.7%, operating cash flow was $3.43B and free cash flow was $2.67B. The quarter ended Jun 30, 2026 had revenue of $4.98B and net income of $377.00M.
Revenue and Margins
The operating margin was 11.8% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $12.48B, a compound annual rate of 6.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $21.84B | +8.2% | 45.4% | 11.8% | 7.7% |
| Sep 2024 | $20.18B | +4.2% | 45.2% | 11.9% | 8.4% |
| Sep 2023 | $19.37B | +2.7% | 42.2% | 10.9% | 7.7% |
| Sep 2022 | $18.87B | -1.4% | 44.9% | 12.1% | 9.4% |
| Sep 2021 | $19.13B | +19.0% | 45.1% | 11.8% | 10.9% |
| Sep 2020 | $16.07B | -7.0% | 42.3% | 5.7% | 5.4% |
| Sep 2019 | $17.29B | +8.2% | 47.9% | 10.2% | 7.1% |
| Sep 2018 | $15.98B | +32.2% | 45.5% | 9.4% | 1.9% |
| Sep 2017 | $12.09B | -3.1% | 49.3% | 12.6% | 9.1% |
| Sep 2016 | $12.48B | N/A | 48.0% | 11.5% | 7.8% |
Income Statement
In the fiscal year ended Sep 2025, net income fell 1.8% from the year before. In the quarter ended Jun 2026, net income fell 34.3% from the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B | $16.07B | $17.29B | $15.98B | $12.09B | $12.48B |
| Cost of revenue | $11.91B | $11.05B | $11.20B | $10.39B | $10.50B | $9.28B | $9.00B | $8.71B | $6.13B | $6.49B |
| Gross profit | $9.93B | $9.13B | $8.17B | $8.48B | $8.63B | $6.80B | $8.29B | $7.27B | $5.96B | $5.99B |
| Research and development | $1.26B | $1.19B | $1.24B | $1.26B | $1.28B | $1.04B | $1.06B | $1.00B | $770.00M | $828.00M |
| Operating income | $2.58B | $2.40B | $2.11B | $2.28B | $2.25B | $912.00M | $1.76B | $1.51B | $1.52B | $1.43B |
| Net income | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B | $874.00M | $1.23B | $311.00M | $1.10B | $976.00M |
| EBITDA | $4.92B | $4.66B | $4.35B | $4.39B | $4.38B | $3.05B | $4.06B | $3.79B | $2.51B | $2.56B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.98B | $4.71B | $5.25B | $7.47B | $4.73B | $4.48B | $5.17B | $5.44B | $4.99B | $5.04B | $4.71B | $5.09B |
| Gross profit | $2.31B | $2.15B | $2.41B | $3.59B | $2.23B | $1.86B | $2.23B | $2.49B | $2.31B | $2.30B | $2.03B | $1.70B |
| Operating income | $663.00M | $93.00M | $552.00M | $1.00B | $739.00M | $383.00M | $453.00M | $622.00M | $602.00M | $734.00M | $439.00M | $349.00M |
| Net income | $377.00M | -$311.00M | $382.00M | $493.00M | $574.00M | $308.00M | $303.00M | $400.00M | $487.00M | $537.00M | $281.00M | $108.00M |
Balance Sheet
As of Sep 2025, total debt of $19.18B exceeded cash and equivalents by $18.61B.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $55.33B | $57.29B | $52.78B | $52.93B | $53.87B | $54.01B | $51.77B | $53.90B | $37.73B | $25.59B |
| Current assets | $9.26B | $10.47B | $8.68B | $8.14B | $8.84B | $8.97B | $6.66B | $7.41B | $18.63B | $6.37B |
| Cash and equivalents | $567.00M | $1.72B | $1.42B | $1.01B | $2.28B | $2.83B | $536.00M | $1.14B | $14.18B | $1.54B |
| Total liabilities | $29.93B | $31.40B | $26.98B | $27.65B | $30.19B | $30.25B | $30.68B | $32.91B | $24.79B | $17.95B |
| Short-term debt | $1.56B | $2.17B | $1.14B | $2.18B | $500.00M | $707.00M | $1.31B | $2.60B | $203.00M | $1.00B |
| Long-term debt | $17.62B | $17.94B | $14.74B | $13.89B | $17.11B | $17.22B | $18.08B | $18.89B | $18.67B | $10.55B |
| Shareholder equity | $25.39B | $25.89B | $25.80B | $25.28B | $23.68B | $23.77B | $21.08B | $20.99B | $12.95B | $7.63B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $50.73B | $50.83B | $54.84B | $55.33B | $54.90B | $54.47B | $54.66B | $57.29B | $55.58B | $54.16B | $52.27B | $52.78B |
| Total liabilities | $26.31B | $26.70B | $29.56B | $29.94B | $29.43B | $29.23B | $29.46B | $31.40B | $29.71B | $28.51B | $26.94B | $26.98B |
| Cash and equivalents | $708.00M | $813.00M | $740.00M | $851.00M | $735.00M | $667.00M | $711.00M | $1.86B | $4.46B | $2.35B | $1.18B | $1.42B |
| Shareholder equity | $24.42B | $24.13B | $25.28B | $25.39B | $25.47B | $25.24B | $25.20B | $25.89B | $25.87B | $25.65B | $25.33B | $25.80B |
Cash Flow
In the fiscal year ended Sep 2025, free cash flow was 77.8% of operating cash flow. Dividends and share repurchases together came to 82.4% of it.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.43B | $3.80B | $2.99B | $2.47B | $4.13B | $2.94B | $3.33B | $2.87B | $2.55B | $2.56B |
| Capital expenditures | $760.00M | $725.00M | $874.00M | $973.00M | $1.19B | $769.00M | $957.00M | $895.00M | $727.00M | $693.00M |
| Free cash flow | $2.67B | $3.07B | $2.12B | $1.50B | $2.93B | $2.17B | $2.37B | $1.97B | $1.82B | $1.87B |
| Dividends paid | $1.20B | $1.10B | $1.11B | $1.08B | $1.05B | $1.03B | $984.00M | $927.00M | $677.00M | $562.00M |
| Share repurchases | $1.00B | $500.00M | $0 | $500.00M | $1.75B | $0 | $0 | N/A | $220.00M | $0 |
| Investing cash flow | -$818.00M | -$5.51B | -$716.00M | -$3.22B | -$1.84B | -$1.19B | -$741.00M | -$15.73B | -$883.00M | -$669.00M |
| Financing cash flow | -$3.62B | $2.09B | -$1.96B | -$736.00M | -$3.31B | $22.00M | -$3.22B | -$58.00M | $10.98B | -$1.76B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $776.00M | $671.00M | $657.00M | $1.85B | $1.09B | -$204.00M | $693.00M | $1.18B | $1.26B | $514.00M | $841.00M | $1.32B |
| Capital expenditures | $143.00M | $125.00M | $108.00M | $377.00M | $164.00M | $114.00M | $105.00M | $296.00M | $179.00M | $134.00M | $116.00M | $294.00M |
| Free cash flow | $633.00M | $546.00M | $549.00M | $1.48B | $925.00M | -$318.00M | $588.00M | $882.00M | $1.09B | $380.00M | $725.00M | $1.03B |
Frequently Asked Questions About BDX
What is Becton Dickinson and Company's annual revenue?
Becton Dickinson and Company reported revenue of $21.84B for the fiscal year ended Sep 30, 2025.
How fast is Becton Dickinson and Company's revenue growing?
Revenue was up 8.2% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.0%.
Is Becton Dickinson and Company profitable?
Yes. Becton Dickinson and Company reported net income of $1.68B for the fiscal year ended Sep 30, 2025, with a net margin of 7.7%.
How much free cash flow does BDX generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $3.43B minus capital expenditures of $760.00M produced free cash flow of $2.67B.
How much debt does Becton Dickinson and Company have?
The balance sheet dated Sep 30, 2025 reported long-term debt of $17.62B, short-term debt of $1.56B and cash and equivalents of $567.00M.
BDX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors